Home
Flashcards
Preview
Pharmacology Exam 3
Home
Get App
Take Quiz
Create
Types of Adrenergic receptors
alpha 1
alpha 2
beta
Targets of Norepinephrine
mono-amine oxidase
COMT
post synaptic membrane
Alpha 1 Adrenergic receptor signaling
GPCR reactions
smooth muscle contraction
Alpha 2 adrenergic signaling
GPCR
inhibition of transmitter release
smooth muscle contraction
Beta adrenergic receptor signaling
heart muscle contration
smooth muscle relaxation
glycogenolysis
Roles of alpha 1 receptors
most vascular smooth muscle
pupillary dialator muscle
pilomotor smooth muscle contraction
prostate contraction
heart contraction
Role of alpha 2 receptors
platelet aggregation
inhibition of neurotransmitters at adr/chol nerve terminals
some vascular smooth muscle contraction
inhibition of lipolysis
inhibition of insulin release
Role of B1 receptors
heart muscle contraction
renin secretion
ghrelin secretion
Role of B2 receptor
smooth muscle relaxation
lipolysis
renin secretion
dialate arteries
relaxation of non-pregnant uterus
B3 role
lipolysis
increase in number of carbons on the amino terminus
increase B (especially B2) selectivity
Addition of OH group on substrates
increases potency (faster metabolism by COMT)
decreases bioavailability
Alpha 1 agonsits
phenylephrine
pupil dilation
increased BP
Alpha 2 agonists
clonidine
treatment of hypertension
neuropathy
sleep disorders
B agonsists
Dobutamine
- heart failure
Terbutaline
- delay premature labor
What is the common funciton of all types of adrenergic receptors?
Muscle contraction
Phenylephrine
potent alpha 1 agonist
administration of phenylephrine
parenteral
oral
local
uses of phenylephrine
dilate pupil
nasal decongestant
Norepinephrine
potent alpha and beta1 receptor agonist
Administration of NE
parenteral
Uses of NE
Used as a pressor
(constricts arteriols to increase BP)
Epinephrine
potent alpha, B1 and B2 agonist
administration of epinephrine
parenteral
uses of epinephrine
anaphylaxis
glaucoma
in combination with local anesthetics
Isoproterenol
non-selective B agonist
bronchodilation
increased cardiac output
administration of isoproterenol
oral
parenteral
local (inhaled)
Uses of isoproterenol
asthma
COPD
cardiostimulant
Which of the following adrenergic agonists are selective to alpha adrenergic receptors?
phenylephrine
competitive antagonist
EC50 decreased but efficacy not changed
Irreversible antagonist
decrease in efficacy because receptor is destroyed
Yohimbine
alpha 2 selective antagonist
aphrodisiac
potential uses of yohimbine
male impotence
depression
obesity
non-insulin dependant DM
same side effects as antidepressants
Yohimbine is metabolized by
CYP3A4 and 2D6
ADR of yohimbine
narrow therapeutic window
anxiety
high BP
rapid HR
hallucination
seizure
renal failure
prazosin decreases the effects of epinephrine mediated action of adrenergic receptors by:
decreasing potency of epinephrine
Phenoxybenzamine (Dibenzyline)
Irreversible antagonist of a1 > a2
higher effect when sympathetic tone is high (upright)
metabolized by 3A4
Uses of phenoxybenzamine
last resort for uncontrolled BP
pheochromocytoma
low bioavailability
Adverse reactions with phenoxybenzamine
postural hypotention
reflex tachycardia
CNS issues
Ejaculation inhibition
Nasal congestion
Miosis (pupil constriction)
Phentolamine (Regitine)
competitive blocker of a1 and a2
medium bioavailability
uses for phentoalmine
extravasation of NE or DA
emergency hypertention (cocain or pheochromocytoma)
shock
pulmonary edema
ED
regional pain syndrome
ADR of phentolamine
Cardiac and CNS related
tachycardia
arrhythmias
mycocardial ischemia
Prazosin (minipres)
alpha 1 selective antagonist
low bioavailabilty due to p-gp efflux
CYP3A4
uses of prazosin
hypertension
BPH
scorpion stings
severe nightmares in children
ADR of prazosin
orthostatic hypotension
loss of consiusness (syncope)
nasal congestion
priapism
Tamsulosin
alpha 1a selective blocker (prostate)
BPH treatment
ADR
: retrograde ejaculation
high bioavailability
CYP3A4 and 2D6
What is the last resort for uncontrolled BP?
A. Prazosin
B. tamsulosin
C. Phenoxybenzamine
D. phentolamine
C. Phenoxybenzamine
uses of beta blockers in heart issues
coronary artery disease
hypertension/arrhythmia
CHF
cardiomyopathy
uses of beta blockers other than the heart
pheochromocytoma
hyperthyroidism
migraine
tremor
anxiety
glaucoma
properties of beta blockers
L-isomer is more potent
B1 (cardiovascular) selectivity
partial agonist activity
Pharmacokinetics of B-blockers
lipid soluble (high bioavailablity)
metabolized in liver
enter the CNS
shorter elimination half lives (fast abs.)
Adverse reactions to beta blockers
cardiac
decresed vascular perfusion
bronchoconstriction
diabetes mellitus
depression, nightmares
withdrawl
Optimal clearance time to decrease ADR of beta blockers
3-4 hours
Pindolol
easily absorbed but not easily metabolized
B-Blockers that have B1=B2 selectivity
propranolol
pindolol
B-Blockers with B1>B2 selectivity
metoprolol
esmolol
Propranolol uses
cardiovascular
migrane
post traumatic stress
glaucoma
Inhibitors of CYP3A4 and CYP2D6
clonidine
quinidine
cimetidine
Induceers of CYP3A4 and 2D6
Phenobarbital
Rifampicin
Propranolol given with inhibior would:
increase efficacy
Propranolol given with an inducer would:
increase efficacy
Metoprolol
many more side effects
serious side effects of metoprolol
very slow HR
cyanosis/tingling of extremities
hair loss
sexual dysfunction
mood change
trouble breathing/cough
Author
Rx2013
ID
43763
Card Set
Pharmacology Exam 3
Description
Adrenergic Agonist/Antagonists
Updated
2010-10-20T19:31:14Z
Show Answers
Home
Flashcards
Preview